Palo Alto Investors

Palo Alto Investors as of Sept. 30, 2023

Portfolio Holdings for Palo Alto Investors

Palo Alto Investors holds 29 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
BioMarin Pharmaceutical (BMRN) 15.3 $162M 1.8M 88.48
Insmed (INSM) 14.1 $149M 5.9M 25.25
United Therapeutics Corporation (UTHR) 12.3 $130M 576k 225.87
Amicus Therapeutics (FOLD) 12.1 $128M 11M 12.16
Biogen Idec (BIIB) 9.3 $98M 381k 257.01
Prothena (PRTA) 7.6 $80M 1.7M 48.25
Revance Therapeutics (RVNC) 5.7 $60M 5.2M 11.47
STAAR Surgical Company (STAA) 5.2 $55M 1.4M 40.18
ACADIA Pharmaceuticals (ACAD) 4.7 $50M 2.4M 20.84
Sage Therapeutics (SAGE) 2.0 $21M 1.0M 20.58
eHealth (EHTH) 1.9 $20M 2.7M 7.40
Align Technology (ALGN) 1.6 $17M 56k 305.32
Alkermes (ALKS) 1.6 $17M 603k 28.01
Sarepta Therapeutics (SRPT) 1.1 $11M 94k 121.22
Novocure Ltd ord (NVCR) 1.0 $11M 660k 16.15
Anaptysbio Inc Common (ANAB) 0.7 $7.7M 431k 17.96
Karyopharm Therapeutics (KPTI) 0.7 $7.6M 5.7M 1.34
Nevro (NVRO) 0.7 $7.4M 387k 19.22
Syndax Pharmaceuticals (SNDX) 0.6 $6.9M 473k 14.52
Gossamer Bio (GOSS) 0.5 $5.4M 6.5M 0.83
Cytokinetics (CYTK) 0.3 $3.3M 112k 29.46
Relmada Therapeutics (RLMD) 0.2 $2.2M 732k 3.00
Mirum Pharmaceuticals (MIRM) 0.2 $2.0M 65k 31.60
Travere Therapeutics (TVTX) 0.1 $1.5M 166k 8.94
Vanda Pharmaceuticals (VNDA) 0.1 $1.2M 279k 4.32
Aldeyra Therapeutics (ALDX) 0.1 $1.1M 161k 6.68
Kezar Life Sciences (KZR) 0.1 $781k 656k 1.19
Tactile Systems Technology, In (TCMD) 0.0 $381k 27k 14.05
Urogen Pharma (URGN) 0.0 $343k 25k 14.01